Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-036860
Filing Date
2023-06-13
Accepted
2023-06-13 18:28:41
Documents
1
Period of Report
2023-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4163
  Complete submission text file 0001209191-23-036860.txt   5502
Mailing Address 55 FRUIT STREET YAWKEY 9E BOSTON MA 02114
Business Address
Flaherty Keith T. (Reporting) CIK: 0001579310 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39743 | Film No.: 231012495

Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Issuer) CIK: 0001797768 (see all company filings)

EIN.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations